| Line 91: | Line 91: | ||
<h3 class="article-title">AFB1</h3> | <h3 class="article-title">AFB1</h3> | ||
<ul class="article-ul"> | <ul class="article-ul"> | ||
| − | |||
| − | |||
| − | |||
| − | |||
<li><a href="http://parts.igem.org/Part:BBa_K1613004">BBa_K1613004</a><span>CYP1A2</span><span><mark>(Basic Part)</mark></span></li> | <li><a href="http://parts.igem.org/Part:BBa_K1613004">BBa_K1613004</a><span>CYP1A2</span><span><mark>(Basic Part)</mark></span></li> | ||
| − | |||
| − | |||
<h4 class="article-h4"> √ A composite part that can detect some toxins.</h4> | <h4 class="article-h4"> √ A composite part that can detect some toxins.</h4> | ||
<p class="article-p">cyp1a2 can oxidize the substances that it can metabolism. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. CYP1A2 is able to metabolize some PAHs to carcinogenic intermediates. Other xenobiotic substrates for this enzyme include aflatoxin B1, and acetaminophen.</p> | <p class="article-p">cyp1a2 can oxidize the substances that it can metabolism. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. CYP1A2 is able to metabolize some PAHs to carcinogenic intermediates. Other xenobiotic substrates for this enzyme include aflatoxin B1, and acetaminophen.</p> | ||
<img src=""> | <img src=""> | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
</ul> | </ul> | ||
</article> | </article> | ||
cyp1a2 can oxidize the substances that it can metabolism. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. CYP1A2 is able to metabolize some PAHs to carcinogenic intermediates. Other xenobiotic substrates for this enzyme include aflatoxin B1, and acetaminophen.